These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Treatment of hepatocellular carcinoma. Blum HE. Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809 [Abstract] [Full Text] [Related]
9. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T. J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115 [Abstract] [Full Text] [Related]
12. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation? Allard MA, Sebagh M, Ruiz A, Guettier C, Paule B, Vibert E, Cunha AS, Cherqui D, Samuel D, Bismuth H, Castaing D, Adam R. J Hepatol; 2015 Jul; 63(1):83-92. PubMed ID: 25646884 [Abstract] [Full Text] [Related]
13. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? Otto G, Schuchmann M, Hoppe-Lotichius M, Heise M, Weinmann A, Hansen T, Pitton MP. J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474 [Abstract] [Full Text] [Related]